Search Results - "Marcos, I M"

Refine Results
  1. 1

    Systematic Review of the Use of Retrievable Inferior Vena Cava Filters by Angel, Luis F., MD, Tapson, Victor, MD, Galgon, Richard E., MD, MS, Restrepo, Marcos I., MD, MS, Kaufman, John, MD

    “…Abstract Purpose To review the available literature on retrievable inferior vena cava (IVC) filters to examine the effectiveness and risks of these devices…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Severe Community-Acquired Pneumonia by Restrepo, Marcos I., MD, MSc, Anzueto, Antonio, MD

    “…Community-acquired pneumonia (CAP) is the leading cause of death from infectious diseases in the United States. It accounts for 500,000 hospitalizations and…”
    Get full text
    Journal Article
  6. 6

    Technologic Advances in Endotracheal Tubes for Prevention of Ventilator-Associated Pneumonia by Fernandez, Juan F., MD, Levine, Stephanie M., MD, FCCP, Restrepo, Marcos I., MD, FCCP

    Published in Chest (01-07-2012)
    “…Ventilator-associated pneumonia (VAP) is associated with high morbidity, mortality, and costs. Interventions to prevent VAP are a high priority in the care of…”
    Get full text
    Journal Article
  7. 7

    Incidence of Cardiovascular Events After Hospital Admission for Pneumonia by Perry, Theodore W., BS, Pugh, Mary Jo V., PhD, Waterer, Grant W., MBBS, FRACP, Nakashima, Brandy, MA, Orihuela, Carlos J., PhD, Copeland, Laurel A., PhD, Restrepo, Marcos I., MD, MSc, Anzueto, Antonio, MD, Mortensen, Eric M., MD, MSc

    Published in The American journal of medicine (01-03-2011)
    “…Abstract Objective Several studies have suggested an increased risk of cardiovascular events, primarily acute myocardial infarction, around the time of…”
    Get full text
    Journal Article
  8. 8

    Predictors of Long-term Mortality After Severe Sepsis in the Elderly by Lemay, Allyson C., BS, Anzueto, Antonio, MD, Restrepo, Marcos I., MD, MSc, Mortensen, Eric M., MD, MSc

    “…Abstract Background Mortality rates after severe sepsis are extremely high, and the main focus of most research is short-term mortality, which may not be…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León by Avellaneda Martínez, C, Santos Pastor, J C, Marcos Sánchez, I M, Narros Giménez, A, Gutiérrez de Antón, M, Alonso Chacón, P

    Published in Revista española de quimioterapia (01-04-2022)
    “…Health and non-health workers (HNH-W) in a hospital are more exposed to SARS-CoV-2 infection than the general population. We studied the prevalence of this…”
    Get full text
    Journal Article
  12. 12

    Pneumonia: An Arrhythmogenic Disease? by Soto-Gomez, Natalia, MD, Anzueto, Antonio, MD, Waterer, Grant W., MBBS, Restrepo, Marcos I., MD, MSc, Mortensen, Eric M., MD, MSc

    Published in The American journal of medicine (01-01-2013)
    “…Abstract Background Recent studies suggest that there is an increase in cardiovascular disease after pneumonia; however, there is little information on cardiac…”
    Get full text
    Journal Article
  13. 13

    What is the Best Antimicrobial Treatment for Severe Community-Acquired Pneumonia (Including the Role of Steroids and Statins and Other Immunomodulatory Agents) by Sibila, Oriol, MD, Restrepo, Marcos I., MD, MSc, Anzueto, Antonio, MD

    “…Community-acquired pneumonia (CAP) is the leading cause of death from infectious diseases in the United States. The mortality rate due to severe CAP has shown…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Impact of Macrolide Therapy in Patients Hospitalized With Pseudomonas aeruginosa Community-Acquired Pneumonia by Laserna, Elena, MD, Sibila, Oriol, MD, Fernandez, Juan Felipe, MD, Maselli, Diego Jose, MD, Mortensen, Eric M., MD, Anzueto, Antonio, MD, Waterer, Grant, MD, Restrepo, Marcos I., MD, FCCP

    Published in Chest (01-05-2014)
    “…Background Several studies have described a clinical benefit of macrolides due to their immunomodulatory properties in various respiratory diseases. We aimed…”
    Get full text
    Journal Article
  16. 16

    Understanding the Concept of Health Care-Associated Pneumonia in Lung Transplant Recipients by Palacio, Federico, MD, Reyes, Luis F., MD, Levine, Deborah J., MD, FCCP, Sanchez, Juan F., MD, FCCP, Angel, Luis F., MD, FCCP, Fernandez, Juan F., MD, Levine, Stephanie M., MD, FCCP, Rello, Jordi, MD, PhD, Abedi, Ali, MD, Restrepo, Marcos I., MD, FCCP

    Published in Chest (01-08-2015)
    “…BACKGROUND Limited data are available regarding the etiologic impact of health care-associated pneumonia (HCAP) in lung transplant recipients. Therefore, our…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Diagnosis of Pulmonary Malignancy after Hospitalization for Pneumonia by Mortensen, Eric M., MD, MSc, Copeland, Laurel A., PhD, Pugh, Mary Jo, PhD, Fine, Michael J., MD, MSc, Nakashima, Brandy, MA, Restrepo, Marcos I., MD, MSc, de Molina, Rosa Malo, MD, Anzueto, Antonio, MD

    Published in The American journal of medicine (2010)
    “…Abstract Background Many physicians recommend that patients receive follow-up chest imaging after the diagnosis of pneumonia to ensure that a pulmonary…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Health Economics of Use Fluoroquinolones to Treat Patients with Community-Acquired Pneumonia by Restrepo, Marcos I., MD, MSc, Frei, Christopher R., PharmD, MSc

    Published in The American journal of medicine (01-04-2010)
    “…Abstract Respiratory diseases account for approximately 10% of all hospital admissions in the United States. Pneumonia constitutes 35% of these cases, with an…”
    Get full text
    Journal Article